NCT05225714 (DERMASILK) is a clinical trial in Contusions, sponsored by Aesculap AG.

Who is sponsoring NCT05225714?

NCT05225714 is sponsored by Aesculap AG.

What condition does NCT05225714 study?

NCT05225714 studies Contusions, Incision, Laceration.

Is NCT05225714 still recruiting?

NCT05225714 is currently completed. Last updated 17 April 2026.

Last reviewed 2026-04-17 · How we verify

NCT05225714: DERMASILK

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dermal Wound Closure Using Silkam®

Completed Last updated 17 April 2026

What this trial tests

trial in Contusions in 161 participants. Completed in 25 June 2025.

Timeline

21 July 2022

Primary endpoint
25 June 2025

25 June 2025

Quick facts

Lead sponsor	Aesculap AG
Status	Completed
Study type	OBSERVATIONAL
Enrollment	161
Start date	21 July 2022
Primary completion	25 June 2025
Estimated completion	25 June 2025
Sites	1 location across Spain

Conditions studied

Contusions — all drugs for Contusions →
Incision — all drugs for Incision →
Laceration — all drugs for Laceration →

Sponsor

Aesculap AG — full company profile →

Who can join

Eligibility, any sex, with Contusions or Incision. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assessment of performance of Silkam® suture material for skin closure. A prospective, single center, single arm, observational study in daily practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Aesculap AG trials

Trials by the same sponsor.

NCT05441618 — Post Market Clinical Follow-Up Study on the Performance and Safety of Lyoplant® · completed
NCT06298500 — Clinical Performance of HISTOACRYL® LAPFIX - CANNULA for Laparoscopic Inguinal Hernia Repair · completed
NCT05944081 — Postmarket Clinical Follow-Up Study on Arcadius XP L® Interbody Fusion Device · withdrawn
NCT06055946 — Symmcora® Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical Prostatect · completed
NCT05182320 — Study Measuring the Effects of Patient Data for Total Hip and Total Knee Arthroplasty Patients Using an APP Based Sensor · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05225714 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aesculap AG
Last refreshed: 17 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05225714.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing